You searched for "endoscopy"
CRSwNP, another monoclonal antibody
Interleukins 4, 5 and 13 were shown to be important factors in type 2 inflammation, which characterises chronic rhinosinusitis with nasal polyposis (CRSwNP). In CRSwNP non-responders and those who recur short after-surgery monoclonal antibodies might be an answer. Examples include...
Early injection laryngoplasty for iatrogenic vocal fold movement impairment – a safe and effective treatment
This Ed’s Choice examines the role of early injection laryngoplasty on swallowing dysfunction and is one of a few studies available in the literature. Research on early injection laryngoplasty has been predominately focused on voice and reducing the risk of...
Patients with severe uncontrolled CRSwNP respond to biologics in the real world
Clinical trials have demonstrated that biologics are effective in treating patients with chronic rhinosinusitis with nasal polyps (CRSwNP). This multicentre (15 tertiary care centres in France) observational prospective cohort study aims to examine the effectiveness of biologics in treating CRSwNP...Advanced in-office awake rhinology
In-office awake rhinology transforms sinonasal care, offering safe, cost-effective, minimally invasive procedures with rapid recovery and high patient satisfaction. In recent years, the landscape of otolaryngological surgery has undergone a remarkable transformation with the advent of in-office awake surgical procedures....Nasal septal perforation repair
Nasal septal perforation repair has traditionally been a great challenge. Many surgical techniques are described, however the success rate of closure has often been poor. Experience from the use of pedicled vascularised mucosal flaps in skull base surgery has been...The central ENT decontamination model: a help or a hindrance?
According to NHS England, over 400,000 patients were waiting for ENT treatment in the UK in January 2022. This figure forms part of the overall 33.5% increase in the number of patients waiting for Referral to Treatment (RTT) compared to February 2020[1].KARL STORZ Strengthens its ENT Portfolio with the Acquisition of AventaMed in Ireland
The family-owned medical technology company KARL STORZ announces the acquisition of 100 percent of the shares of AventaMed DAC, an Irish medical technologies company.Enhancing surgical outcomes in TOETVA – with neuromonitoring essentials by Langer Medical
Intraoperative neuromonitoring has become a standard practice in all thyroid surgery, allowing for the precise localisation and reliable monitoring of neurophysiological structures at-risk.KARL STORZ acquisition of assets from Diaspective Vision
KARL STORZ is pleased to announce the acquisition of assets from Diaspective Vision, a Germany-based business that has driven innovations in the field of spectral camera solutions for medical applications since 2015. Employees from Diaspective Vision will join the KARL...The impact of simulation on ENT training
Surgical training is constantly developing to improve ENT surgeons’ technical and non-technical skills. In this article, Joshua Whittaker, an ENT Registrar and ENT Simulation Fellow at University Hospitals Birmingham, describes the rise of simulation training. Simulation is the recreation of...Navient receives FDA 510(k) clearance for ENT procedures
CKI (ClaroNav Kolahi Inc.) has received FDA 510(k) clearance for Navient in ENT procedures, expanding its previous clearance for cranial applications. Navient is now approved by major global regulatory bodies, including Canada (HC), Europe (EU MDD), China (NMPA), UAE, Saudi...
